TP53 and glioblastoma: Due to the heterogeneic nature of GBM, we propose the possible mechanisms for which TP53 mutated: (i) in a clonal event during a later stage of G52 tumour development before branching off to form G53 or (ii) parallel genetic evolution of a G52 tumour cell that accumulated this aberration during tumorigenesis of G53.